Member Info for roger65

Well, I find it annoyingly ironic that no sooner have I decided the sp isn’t after all going to drop significantly lower and so begin to build a stake, that a shed load of delayed trades appear giving no clue as to what’s really going on behind the scenes. Looking at things positively I can imagine a potential partner has begun making a move and is now building a stake…? MMS obliging as per usual? Or as I said earlier is it Ketan setting up the transfer of shares from some major holders to a new potential partner using otc trading, which can be reported late and also repeatedly if they can show LSE it’s a fair balance of trades and thus not skewing the market picture or making it overly volatile. Who knows. It will be just my luck if there is an RNS by the end of January which sends the sp parabolic

Likewise. Let’s hope Tim doesn’t disappoint again. I’ve bought £5k worth in between Xmas and NY so really hoping nothing unforeseen occurs such that the CEO can once again deliver news which he tells us ‘it’s actually good news for shareholders holders..’ when it’s blindingly obvious it’s not good news! The man has some cheek but it’s how Directors operate on AIM so he’s just playing the game I guess and ensuring IMM continues to exist so it can pay his monthly salary. I’m hoping for him to be rewarded with a massive retirement payout instead though, come March/April, by which time I will hopefully have built up my own personal stake once again.

Even if it’s not Stubben Edge looking at MAC I’d think someone out there must be eyeing this up. Far quicker and cheaper way to gain LSE listing. Buy Marechale for £7m or £8m and base that on the value of 8% investment in Weardale. £8m for an 8% stake and whilst it’s already cheap take a further chunk of Weardale by increasing the stake before they get going with the Plant construction. Wish had a spare few million quid. This could so easily find itself the centre of attention for the AIM retail herds. And we all know what crazy things can happen then. Just needs a little help lighting the touch paper…..

Why it's Attractive (Quick & Cheaper than IPO):

Speed: Avoids lengthy IPO processes, potentially faster market entry.

Cost: Can be less expensive than underwriting a full IPO.

Yep, almost double what the UK govt Has committed to the whole of the UK critical minerals policy - covering ALL critical materials listed, not just lithium. Germans know what they’re doing though. Uk govts for last 50yrs have all been inept at sensibly assessing the nation’s future needs. Too little too late. Again. By the time they try to do anything meaningful it will be too late and we will be playing catch up with the other major economies. Embarrassing really.

The Chinese issue will accelerate the price increases for Lithium and then probably a foreign business entity will take Weardale on and most of the profit will end up leaving the UK and end up in the accounts of a global financial powerhouse eg Black Rock or Vanguard. Anyway, I don’t care where the profit eventually ends up as long as the project is advanced soon and I can exit this turgid stock once and for all with something approaching a profit!

Volume today, excl all the late reported trades, was £70k. The late reported trades totalled more than £200k so something is going on but all hidden from view. Could be otc trades managed by Ketan btwn different parties so might be cancelling each other out. One thing is for sure though, if they were all buys the sp would be much higher. If all sells then accordingly much lower. Share price has remained stable so is this Ketan doing his thing for the company in attracting new investors and acting as a go-between for someone wanting to sell out? Could still be Lanstead I suppose…? Just no way of knowing but either way that’s a heck of a lot of money changing hands - if someone is selling then of course someone is buying them all up- and vice versa. Enjoy your evening everyone. 2025 is the year of delivery for IMM. Uh sorry, I meant 2026! Lol

Ffs *stake! Predictive text nightmares continue…

Not so sure that would be a good thing for shareholders here. Why? Because it would be likely that those high net worth individuals putting money into Weardale would want to see our 8% steak diluted or they may ask for match funding and if someone goes in and puts 5 million quid down, then we have no choice but to accept a dilution because we simply don’t have anything like that cash to put in. In my view the best possible outcome is the government gives Weardale a grant and that kicks off some funding for Wardale which sees their valuation rise sharply and thus our share price would also go up. I guess one other possibility is that where Oli in order to get a public listing to a reverse take over Marechale

* correlation Not coalition!

Sadly still stillwaiting the value of Weardale hasn’t increased since approval for the development of the site was given 10min this ago. In that time Lithium has increased almost by 100% so there is obviously no coalition between the two.

The big sticking point at the moment - and why I’m so frustrated and appalled by the snail pace action of the uk govt - is this statement last February in the RNS

‘ Weardale will now seek to advance the development of the site, with the pilot stage of the development expected to be completed in 18 to 24 months. Weardale will continue to liaise with Durham City Council in regard to the build out.’

Since then Weardale have not advanced the project at all and into either they find some investors or the uk govt put some funding into this then it will go nowhere.

Seems crazy to me that Stubbens doesn’t snap up MAC for say £6m (3x current value), get itself in the LSE quickly and cheaply whilst buying a significant stake in Weardale, which, according to the Company is now sitting on a project with the potential to make over £1bn. And that was stated 10 months ago, since when the price of lithium has pet much doubled. I find it inconceivable that there is no one looking at this as a hugely undervalued opportunity. We’ll probably wake up one day and before you can blink it’ll be announced MAC has been made an incredibly modest offer. It may well end up being 3 or 4 x the mcap but it’ll only be a fraction of the potential value gained from an 8% stake in a project that could now end up being worth more like £2bn !

Not yet OSD. I’m waiting for some Divine intervention or miraculous sign before I worship at the shrine of IMM again. Whatever the deal might be it’s obviously not going to be for a month or two at the very least. Plenty of time

Personally I prefer the idea of a complete buyout and IMM ceases to exist. For the good of the world P140 needs to be developed as quickly as possible and I don’t see IMM’s 6 employees and greedy CEO improving matters much if a Major takes it all on. They’ll want Tim out of the picture and might just take on the scientists but frankly I doubt it. Tim’s business acumen would add zip to any major (or minor come to think about it) pharma’s management team! I think he’ll end up taking an incredibly handsome retirement payment what with all his shares and options. Several million quid!

I think if Tim and his team try to be greedy and stay involved they might scupper a really good deal for shares holders ie a full take over. It’s the P140 IP that is of interest, not the managerial skills - or lack of - of the tiny IMM outfit. I hope Ketan sees this all as a short term interest for himself ie help negotiate a huge deal and walk away with a lump sum for just a few months work.

CtAI mcap only £3.15m as of today, so it wouldn’t take much to secure that 13% stake at a far cheaper price than if someone waited for concrete evidence that Alludium was going to be bought for say £100m by the likes of Nvidia or similar. This seems undervalued atm and yet has the potential to explode. Or is it just me dreaming?

If some big player became seriously interested in Alludium, wouldn’t it make sense to first the 13% stake that CTAI own before it takes off?

Anyone else think Mac might be bought out? If any entity was interested in Weardale then easily buying up 8% of it whilst the valuation is so low and before it really takes off would seem like a sensible thing to do, yes? Not to mention the value in gaining a quick and easily acquired vehicle for a RTO and hey presto you have a place on the London Stock Exchange.

Delayed payment then by the looks of it.

Why?

Klarian doesn’t have that much cash atm? Or are they holding out because they think CtAI might not last that long And if it folded they’ll save over half a million quid? Or are they hoping ctAI will be bought out by another larger entity and the payment will be cancelled? Don’t see this last option as very likely at all.

As always those delayed trades are printed late to deliberately leave retail guessing. No way of knowing but….when Lanstead were dumping until late NOV they rarely hit trades worth that much! So, is there a new seller? More likely imo a new buyer who wants to quickly build a stake for some reason. As per usual mms are obliging in any way they can.

£100m because Tim has only mentioned licensing deals and without the appeal of the US market the majors might walk away and IMM are left with some of the smaller potential partners which won’t have such deep pockets. Not ridiculous by any means. What IS ridiculous is this manic impulse to refuse to believe anything other than a huge deal might transpire.

‘ can you imagine the revenue from treating 80% of autoimmune patients worldwide, ’

Apart from the US, the rights to which remain with Avion, not IMM. Some folks on here seem to think that’s a really good thing. Who ever wants P140 will definitely want the US but they will have to pay Avion handsomely for it. If the Avion issue can’t be resolved then I feel it will be a much smaller license deal in the region of £100m . But that would STILL result in a share price of about 20p which would see a rise of more than 200% which would be fantastic. Obviously everyone would prefer a complete buyout but Tim hasn’t mentioned that as a possibility once. You never know. I can’t see any of the top ten global pharmas being keen on working hand in hand with IMM’s team of 6 employees going forwards commercialising P140 worldwide. All sense suggests a buyout would make more sense for any of the big boys but it’s all a case of whether Tim has over egged the scientific side of things to maximise what IMM could get from the Lanstead agreement. It worked extremely well as a play and the timing was perfect - almost to the day the agreement came to an end Tim cdnt get that RNS out quick enough announcing a delay. He told share holders to ‘keep the faith’ but he’s done that before. Seven years ago to be precise and P140 still hasn’t commenced its final Phase III trials.

Sorry, £560k with an extra £56k due if they are late with it.

If Klarian don’t pay then it could well be curtains for Mac as they have no cash to pay legal fees and go chasing payment

Sorry, £560k with an extra £56k due if they are late with it.